Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
21
Recruiting, any sponsor type, condition "gout"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed201
21 trials
Showing 1 to 21, recently updated first.
- Combined Metabolic Activator Supplementation in Subjects Diagnosed With GoutPivotal-lookingRecruiting
ScandiBio Therapeutics ABIndustry
NCT07889284 · 336 participants (planned) · Start Nov 4, 2026 · Primary completion Feb 2027
Drug: Combined metabolic activators · For: Gout Disease
Sites: Ankara, Turkey (Türkiye); Antalya, Turkey (Türkiye); Erzurum, Turkey (Türkiye) · 12 sites in all
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutPivotal-lookingRecruiting
Massachusetts General HospitalAcademic, hospital or other
NCT04875702 · 650 participants (planned) · Start Feb 22, 2024 · Primary completion Sep 1, 2028
Drug: Allopurinol; Naproxen 250 MG and 4 more · For: Gout
Sites: Birmingham, Alabama; Santa Monica, California; Boston, Massachusetts · 7 sites in all
- ACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis FlaresPivotal-lookingRecruiting
ANI PharmaceuticalsIndustry
NCT07938164 · 160 participants (planned) · Start Jan 28, 2026 · Primary completion Nov 30, 2027
Drug: Purified Cortophin Gel, 40 U; Purified Cortophin Gel 80 U · For: Acute Gouty Arthritis
Sites: Boston, Massachusetts
- A Study of Dotinurad Versus Allopurinol in Participants With GoutPivotal-lookingRecruiting
Crystalys TherapeuticsIndustry
NCT07089875 · 500 participants (planned) · Start Aug 1, 2025 · Primary completion Nov 29, 2027
Drug: Allopurinol; Dotinurad · For: Gout
Sites: Birmingham, Alabama; Foley, Alabama; Gilbert, Arizona · 122 sites in all
- A Study of Dotinurad Versus Allopurinol in Tophaceous GoutPivotal-lookingRecruiting
Crystalys TherapeuticsIndustry
NCT07089888 · 250 participants (planned) · Start Aug 4, 2025 · Primary completion Dec 31, 2027
Drug: Allopurinol; Dotinurad · For: Tophaceous Gout
Sites: Birmingham, Alabama; Foley, Alabama; Gilbert, Arizona · 99 sites in all
AmgenAmgen (AMGN)
NCT07388498 · 270 participants (planned) · Start Feb 9, 2026 · Primary completion Jun 18, 2028
Drug: Pegloticase; Methotrexate · For: Uncontrolled Gout
Sites: Birmingham, Alabama; Anchorage, Alaska; Searcy, Arkansas · 75 sites in all
Mostafa BahaaAcademic, hospital or other
NCT06924658 · 70 participants (planned) · Start Apr 20, 2025 · Primary completion Nov 20, 2027
Drug: Metformin · For: Gout
Sites: Tanta, Egypt
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)Pivotal-lookingRecruiting
ProtalixIndustry
NCT07280156 · 150 participants (planned) · Start Dec 22, 2025 · Primary completion Dec 2027
Drug: PRX-115; Methotrexate (MTX) · For: Gout
Sites: Glendale, Arizona; Little Rock, Arkansas; Anaheim, California · 35 sites in all
Crystalys TherapeuticsIndustry
NCT07535034 · 90 participants (planned) · Start May 8, 2026 · Primary completion Jul 2027
Drug: Dotinurad · For: Gout
Sites: Birmingham, Alabama; Phoenix, Arizona; Tucson, Arizona · 41 sites in all
Massachusetts General HospitalAcademic, hospital or other
NCT06674109 · 60 participants (planned) · Start Jul 1, 2026 · Primary completion Feb 1, 2028
Drug: Empagliflozin 10 mg; Placebo · For: Gout and Hyperuricemia
Sites: Boston, Massachusetts
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAcademic, hospital or other
NCT07587684 · 16 participants (planned) · Start Jun 12, 2026 · Primary completion Aug 2027
Drug: IN026 Injection · For: Refractory Gout
Sites: Wuhan, China
- the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or MoreRecruiting
Seoul National University HospitalAcademic, hospital or other
NCT06622603 · 59 participants (planned) · Start Sep 10, 2025 · Primary completion Feb 19, 2027
Drug: Febuxostat · For: Gout; Uric Acid
Sites: Seongnam-si, South Korea
- The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and HyperuricemiaPivotal-lookingRecruiting
Jiangsu HengRui Medicine Co., Ltd.Industry
NCT07362355 · 340 participants (planned) · Start Feb 9, 2026 · Primary completion Jul 2027
Drug: SHR4640 ;Febuxostat; SHR4640 ; Febuxostat and 3 more · For: Primary Gout and Hyperuricemia
Sites: Shanghai, China
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePivotal-lookingRecruiting
Olatec Therapeutics, Inc.Industry
NCT05658575 · 300 participants (planned) · Start Jan 6, 2023 · Primary completion Dec 31, 2026
Drug: Dapansutrile · For: Acute Gout Flare; Gout Attack; Gout Flare and 4 more
Sites: Birmingham, Alabama; Glendale, Arizona; Mesa, Arizona · 40 sites in all
- Time Required to Dissolve Urate DepositsRecruiting
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT06669000 · 250 participants (planned) · Start Sep 24, 2024 · Primary completion Sep 24, 2032
Drug: DNA sample; Serum collection · For: Gout
Sites: Paris, France
- Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout FlaresPivotal-lookingRecruiting
Massachusetts General HospitalAcademic, hospital or other
NCT07346079 · 150 participants (planned) · Start Dec 20, 2025 · Primary completion Aug 31, 2027
Drug: Purified Cortophin Gel, 40 U; Purified Cortophin Gel 80 U · For: Gout Arthritis; Gout Flare; Gout
Sites: Boston, Massachusetts
Shanghai Institute Of Biological ProductsIndustry
NCT06298071 · 36 participants (planned) · Start Mar 3, 2023 · Primary completion Dec 30, 2026
Drug: SIBP-R002; SIBP-R002 and 2 more · For: Gout
Sites: Bengbu, China
- Effect of Dotinurad in Hyperuricemia With HypertensionPivotal-lookingRecruiting
Saga UniversityAcademic, hospital or other
NCT06834230 · 360 participants (planned) · Start Mar 28, 2025 · Primary completion Jul 31, 2027
Drug: Dotinurad; Febuxostat · For: Hyperuricemia or Gout; Hypertension
Sites: Saga, Japan
Shenyang Sunshine Pharmaceutical Co., LTD.Industry
NCT06629376 · 60 participants (planned) · Start Nov 20, 2023 · Primary completion Dec 20, 2026
Drug: Pegylated Recombinant Candida Utilis Uricase for Injection · For: Gout; Hyperuricemia
Sites: Shanghai, China
- Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release TabletsPivotal-lookingRecruiting
Huashan HospitalAcademic, hospital or other
NCT06966635 · 312 participants (planned) · Start Apr 10, 2024 · Primary completion Dec 31, 2025
Drug: Sodium Bicarbonate Oral Capsule; Potassium Citrate Tablets and 1 more · For: Hyperuricemia or Gout; Nephrolithiasis
Sites: Shanghai, China
- Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout ArthritisPivotal-lookingRecruiting
Laboratorios Silanes S.A. de C.V.Industry
NCT06863701 · 72 participants (planned) · Start Jan 27, 2025 · Primary completion Dec 31, 2026
Drug: Etoricoxib + Betamethasone fixed dose; Etoricoxib fixed dose · For: Gout Arthritis; Gout Attack
Sites: Mexico City, Mexico
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.